The AMA calls for retaining USPSTF members to ensure continuity of evidence-based preventive care services covered by insurers under federal law, highlighting the task force's crucial role in U.S. public health.

The Trump administration proceeds with the third cycle of Medicare drug price negotiations, addressing Part B drug inclusion and sparking pharmaceutical industry concerns about pricing and implementation.